January 29, 2025CorporateCarter BloodCare First to Complete the Transition to Automated Whole Blood Processing With Terumo Blood and Cell Technologies
January 21, 2025CorporateTerumo Blood and Cell Technologies and Akron Bio Complete Collaborative Study on MSC Expansion Using Quantum FlexStudy confirms that Terumo BCT’s Quantum Flex platform, paired with Akron Bio’s GMP virus-inactivated fibronectin reagent, provides a scalable and compliant solution for MSC expansion
FYE 3/2024 FYE 3/2023 FYE 3/2022 FYE 3/2020 FYE 3/2019 FYE 3/2018 FYE 3/2017 FYE 3/2024 Consolidated Financial Statements (PDF 1.11 MB) FYE 3/2023 Consolidated Financial Statements (PDF 1.31 MB) Consolidated Financial Statements (PDF 1.31 MB) FYE 3/2022 Consolidated Financial Statements (PDF 1.19 MB) Consolidated Financial Statements (PDF 1.19 MB) FYE 3/2020 Consolidated Financial Statements (PDF 1.48 MB) FYE 3/2019 Consolidated Financial Statements (PDF 1.52 MB) FYE 3/2018 Consolidated Financial Statements (PDF 1.77 MB) FYE 3/2017 Consolidated Financial Statements (PDF 2.93 MB) Adobe Reader (free) is required to view PDF files. Download Adobe Reader
FYE 3/2023 Consolidated Financial Statements (PDF 1.31 MB) Consolidated Financial Statements (PDF 1.31 MB)
FYE 3/2022 Consolidated Financial Statements (PDF 1.19 MB) Consolidated Financial Statements (PDF 1.19 MB)